PKCι maintains a tumor-initiating cell phenotype in KRAS LADC
PKCι phosphorylates and recruits ELF3 to the NOTCH3 promoter
PKCι-ELF3-NOTCH3 signaling drives LADC tumor formation
Combined PKCι and NOTCH blockade synergistically inhibits KRAS LADC growth in vivo